IRIS
CORTI, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.115
NA - Nord America 740
AS - Asia 372
AF - Africa 5
OC - Oceania 1
SA - Sud America 1
Totale 2.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 740
SE - Svezia 670
SG - Singapore 255
RU - Federazione Russa 220
CN - Cina 76
IT - Italia 68
FI - Finlandia 55
DE - Germania 49
IE - Irlanda 38
IN - India 32
GB - Regno Unito 6
EG - Egitto 5
IR - Iran 5
NL - Olanda 5
JP - Giappone 3
RO - Romania 2
AU - Australia 1
CL - Cile 1
IQ - Iraq 1
NO - Norvegia 1
UA - Ucraina 1
Totale 2.234
Salva come PNG Salva come JPEG
Città #
Lawrence 266
Princeton 266
Singapore 148
Helsinki 55
Shanghai 55
Moscow 53
Ashburn 45
Dublin 38
Milan 32
New York 32
Pune 32
Boardman 19
Los Angeles 10
Seattle 9
Washington 5
Alexandria 4
Borås 4
San Diego 4
Ancona 3
Brescia 3
London 3
Rome 3
Maropati 2
Naaldwijk 2
Pisa 2
Tanta 2
Teverola 2
Tokyo 2
Zanjan 2
Abingdon 1
Arbil 1
Arnsberg 1
Bergen 1
Böblingen 1
Chiaravalle 1
Falconara Marittima 1
Ferrara 1
Frankfurt am Main 1
Genoa 1
Gunzenhausen 1
Hanover 1
Henderson 1
Honolulu 1
Karasawa 1
Kashan 1
Kish 1
Kortenhoef 1
Mainz 1
Missaglia 1
Mountain View 1
Newcastle 1
Nuremberg 1
Osimo 1
Rockville 1
Sacramento 1
San Francisco 1
San Mateo 1
Santiago 1
Secaucus 1
Spalding 1
Tehran 1
Temecula 1
Torino 1
Woodbridge 1
Totale 1.138
Salva come PNG Salva come JPEG
Nome #
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma 26
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 22
A pilot phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma 20
CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study 19
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models 18
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 18
Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA(1-64)) in the rat heart 17
Chromogranin-A production and fragmentation in patients with Takayasu arteritis. 17
Anti-urokinase monoclonal antibody, matrix bearing it, test method, biochemical test kits which use it. 17
Ways to improve tumor uptake and penetration of drugs into solid tumors 17
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma 17
Breaching the blood–brain tumor barrier for tumor therapy 17
Isoaspartate-glycine-arginine: A new tumor vasculature-targeting motif 16
Aminopeptidase N (CD13)-positive bone marrow-derived cells induce angiogenesis and tumor growth: A potential non-malignant immune cell target against cancer 16
Altered Chromogranin A Circulating Levels in Meniere’s Disease 16
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: Final results of a phase 2 trial 16
An innovative platform approach for the development of ex-vivo gene therapies for the treatment of lysosomal storage diseases with skeletal involvement 16
Chromogranin A plasma levels predict mortality in COVID-19 15
Catestatin inhibits obesity-induced macrophage infiltration and inflammation in the liver and suppresses hepatic glucose production, leading to improved insulin sensitivity 15
Nanogold Functionalized With Lipoamide-isoDGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting 15
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours 14
T cells redirected to a minor histocompatibility antigen instruct intratumoral TNFα expression and empower adoptive cell therapy for solid tumors 14
Spatiotemporal regulation of tumor angiogenesis by circulating chromogranin a cleavage and neuropilin-1 engagement 14
A receptor-antibody sandwich assay for teicoplanin. 13
[Activation and role of the tumor necrosis factor-alpha in congestive heart failure]. FT Attivazione e ruolo del fattore di necrosi tumorale alfa nello scompenso cardiaco congestizio. 13
Immobilized oligopeptides 13
Process for identifying polynucleotide sequences and device suitable therefor 13
Anti-idiotype monoclonal antibody directed against anti-TNF antibodies 13
Cromogranina A per uso come reagente in un metodo diagnostico o prognostico 13
Won't you come on in? How to favor lymphocyte infiltration in tumors 13
Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study 13
Overexpression of the hereditary hemochromatosis protein, HFE, in HeLa cells induces and iron-deficient phenotype 13
Affinity enhancement of complementary peptide recognition 13
A new chromogranin A-dependent angiogenic switch activated by thrombin 13
Vascular targeting, chemotherapy and active immunotherapy: teaming up to attack cancer 12
Commentary: Granins, Secretory Granule Biogenesis, and Transport 12
Vascular attack and immunotherapy: a 'two hits' approach to improve biological treatment of cancer 12
Conversation galante: How the immune and the neuroendocrine systems talk to each other 12
Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications, and alternative roads 12
Immunohistochemistry of HFE in the duodenum of C282Y homozygotes with antisera for recombinant HFE protein 12
Agents regulating vascular permeability 12
Solid-phase receptor assay for antibiotics of the vancomycin class. 12
Monoclonal antibodies against the TNF type-I receptor, process for their production and use thereofAnticorpi monoclonali anti-recettore di tipo 1 del TNF alfa, procedimento per la loro produzione e loro uso 12
Fusion of cytokines and targeting peptides 12
Circulating chromogranin A 12
Autocrine saturation of pro-urokinase receptors on human A431cells 12
Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion 12
Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging 12
A monoclonal antibody that recognizes the receptor binding region of human urokinase plasminogen activator. 12
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity 12
The chromogranin A1-373 fragment reveals how a single change in the protein sequence exerts strong cardioregulatory effects by engaging neuropilin-1 12
Identification of differentially glycosylated forms of the soluble p75 tumor-necrosis-factor (TNF) receptor in human urine 11
Oxidative stress biomarkers and chromogranin A in uremic patients: Effects of dialytic treatment 11
Liposome-Mediated Therapy of Neuroblastoma 11
Tumor necrosis factor in heart failure 11
Targeting macrophages sensitizes chronic lymphocytic leukemia to apoptosis and inhibits disease progression 11
Chromogranin A is preferentially cleaved into pro-angiogenic peptides in the bone marrow of multiple myeloma patients 11
Cytokine conjugates (IL-12 –peptide conjugates) 11
Tumor Necrosis Factor: methods and protocols 11
Modified cytokines for therapeutic use 11
Receptor-antibody sandwich assay. 11
Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis 11
Vasostatins 11
Succinimide-Based Conjugates Improve IsoDGR Cyclopeptide Affinity to αvβ3 without Promoting Integrin Allosteric Activation 11
Purification and characterization of single-chain urokinase-type plasminogen activator (pro-urokinase) from human A431 cells. 11
A stapled chromogranin A-derived peptide homes in on tumors that express αvβ6 or αvβ8 integrins 11
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods 10
The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key? 10
Nitric oxide synthase in CHF - Reply 10
Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy 10
Tumor necrosis factor in congestive heart failure: A mechanism of disease for the new millennium? 10
Oral direct thrombin inhibition: a double-edged sword? 10
Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A 10
STRUCTURAL BASIS FOR THE INTERATION OF ISODGR WITH RGD-BINDING SITE OF αvβ3 INTEGRIN 10
Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. 10
NGR-Tagged Nano-Gold: a new CD13-selective carrier for cytokine delivery to tumors 10
Kinetic-analysis of TNF-alpha oligomer monomer transition by surface-plasmon resonance and immunochemical method 10
Binding of the glycopeptide antibiotic teicoplanin to D-alanyl-D-alanine-agarose: the effect of micellar aggregates. 10
Functional expression of two soluble forms of the TNF-receptor type I in mammalian cells 10
Targeted delivery of TNF using NGR-TNF in combination with chemotherapy as an effective and tolerable strategy in a hepatocarcinoma patient 10
Targeted delivery of IFN gamma to tumor vessels uncouples antitumor from counterregulatory mechanisms 10
Tumor necrosis factor-α as a master regulator of inflammation in Erdheim-Chester disease: rationale for the successful treatment of patients with infliximab 10
High blood levels of chromogranin A in giant cell arteritis identify patients refractory to corticosteroid treatment 10
Quantification of Chromogranin A and Its Fragments in Biological Fluids 9
Chromogranin A Restricts Drug Penetration and Limits the Ability of NGR-TNF to Enhance Chemotherapeutic Efficacy 9
Influence of vasostatins, the chromogranin A-derived peptides, on the working heart of the eel (Anguilla anguilla): negative inotropy and mechanism of action 9
Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas 9
Targeted drug delivery and penetration into solid tumors. 9
Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha 9
Tumor targeting with biotinylated tumor necrosis factor alpha: Structure-activity relationships and mechanism of action on avidin pretargeted tumor cells 9
Synthesis and characterization of D-alanyl-D-alanine-agarose: a new bioselective adsorbent for affinity chromatography of glycopeptide antibiotics 9
Full-length human Chromogranin-A cardioactivity: myocardial, coronary and stimulus-induced processing evidence in normotensive and hypertensive male rat hearts 9
Immunoconjugates for treatment of tumors 9
Process for the identification of proteolytic activity and / or inhibitors thereof 9
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease 9
Regulation of tumor growth by circulating full-length chromogranin A 9
TUMOUR NECROSIS FACTOR-ALPHA AS A MASTER REGULATOR OF INFLAMMATION IN ERDHEIM-CHESTER DISEASE: RATIONALE FOR THE SUCCESSFUL TREATMENT OF TWO PATIENTS WITH INFLIXIMAB 9
Spontaneous formation of L-isoaspartate and gain of function in fibronectin 9
Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers 9
Tumor cell-associated immune checkpoint molecules – Drivers of malignancy and stemness 9
Totale 1.227
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.175
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.175
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202016 9 1 1 0 0 0 0 0 1 3 1 0
2020/20215 0 0 0 1 0 0 4 0 0 0 0 0
2021/2022111 0 0 0 70 0 7 7 5 2 2 1 17
2022/20231.296 604 245 115 3 2 138 42 67 64 5 5 6
2023/2024419 5 8 62 36 26 88 24 33 0 18 37 82
2024/2025442 442 0 0 0 0 0 0 0 0 0 0 0
Totale 2.354